Skip to main content
logo
Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.870
-0.150 (-3.73%)
Aug 27, 2026, 4:08 PM HKT

HKG:2591 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Capitalization
1,83613,997--
Market Cap Growth
-92.36%---
Enterprise Value
83013,255--
Last Close Price
4.0230.64--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
10.3895.64--
PB Ratio
1.6911.94--
P/TBV Ratio
1.7312.19--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
4.6990.57--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.160.160.010.07
Net Debt / Equity Ratio
-0.99-0.99-0.99-0.92
Net Debt / EBITDA Ratio
3.063.064.500.88
Net Debt / FCF Ratio
3.293.294.723.67
Asset Turnover
0.110.11--
Inventory Turnover
0.200.20--
Quick Ratio
2.672.675.821.94
Current Ratio
2.932.936.072.66
Return on Equity (ROE)
-36.91%-36.91%-23.27%-
Return on Assets (ROA)
-17.30%-17.30%-11.61%-
Return on Capital Employed (ROCE)
-32.50%-32.50%-23.80%-100.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-21.02%-2.71%--
FCF Yield
-22.79%-2.51%--
Buyback Yield / Dilution
-3.44%-3.44%-9.63%-